| Production of the antimalarial drug precursor artemisinic acid in engineered yeast DK Ro, EM Paradise, M Ouellet, KJ Fisher, KL Newman, JM Ndungu, ... Nature 440 (7086), 940-943, 2006 | 3476 | 2006 |
| Engineering of the pyruvate dehydrogenase bypass in Saccharomyces cerevisiae for high-level production of isoprenoids Y Shiba, EM Paradise, J Kirby, DK Ro, JD Keasling Metabolic engineering 9 (2), 160-168, 2007 | 394 | 2007 |
| High‐level production of amorpha‐4, 11‐diene in a two‐phase partitioning bioreactor of metabolically engineered Escherichia coli JD Newman, J Marshall, M Chang, F Nowroozi, E Paradise, D Pitera, ... Biotechnology and bioengineering 95 (4), 684-691, 2006 | 325 | 2006 |
| Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid DK Ro, M Ouellet, EM Paradise, H Burd, D Eng, CJ Paddon, JD Newman, ... BMC biotechnology 8, 1-14, 2008 | 218 | 2008 |
| Redirection of flux through the FPP branch‐point in Saccharomyces cerevisiae by down‐regulating squalene synthase EM Paradise, J Kirby, R Chan, JD Keasling Biotechnology and bioengineering 100 (2), 371-378, 2008 | 167 | 2008 |
| Engineering triterpene production in Saccharomyces cerevisiae–β‐amyrin synthase from Artemisia annua J Kirby, DW Romanini, EM Paradise, JD Keasling The FEBS journal 275 (8), 1852-1859, 2008 | 153 | 2008 |
| Genetically modified host cells and use of same for producing isoprenoid compounds Y Shiba, J Kirby, EM Paradise, JD Keasling US Patent App. 12/063,831, 2009 | 20 | 2009 |
| Genetically modified host cells and use of same for producing isoprenoid compounds JD Keasling, EM Paradise, J Kirby | 20* | 2006 |
| Polynucleotides encoding isoprenoid modifying enzymes and methods of use thereof DK Ro, K Newman, EM Paradise, JD Keasling, M Ouellet, R Eachus, K Ho, ... US Patent 8,163,980, 2012 | 10 | 2012 |
| Genetically modified host cells and use of same for producing isoprenoid compounds JD Keasling, J Kirby, EM Paradise US Patent 10,435,717, 2019 | 4 | 2019 |
| Polynucleotides encoding isoprenoid modifying enzymes and methods of use thereof DK Ro, K Newman, EM Paradise, JD Keasling, M Ouellet, R Eachus, K Ho, ... | 3 | 2017 |
| Genetically modified host cells and use of same for producing isoprenoid compounds JD Keasling, J Kirby, EM Paradise US Patent App. 16/554,125, 2019 | | 2019 |
| Polinucleótidos que codifican enzimas modificadoras de isoprenoides y procedimientos de uso de los mismos DK Ro, K Newman, EM Paradise, JD Keasling, M Ouellet, R Eachus, K Ho, ... ES Patent App. 06,785,959 T, 2012 | | 2012 |
| Polynucleotider kodende for isoprenoid-modificerende enzymer og fremgangsmåder til anvendelse deraf DK Ro, K Newman, EM Paradise, JD Keasling, M Ouellet, R Eachus, K Ho, ... | | 2012 |
| Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an DK Ro, M Ouellet, E Paradise | | 2008 |
| Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid. RDK Ro DaeKyun, M Ouellet, EM Paradise, H Burd, D Eng, CJ Paddon, ... | | 2008 |
| Strain Engineering and Fermentation Process Development toward Supplying Semi-Synthetic Artemisinin. A Key Component of Antimalarial Combination Therapies R Regentin, CJ Paddon, P Westfall, H Tsuruta, DJ Pitera, DJ Eng, ... The 2008 Annual Meeting, 2008 | | 2008 |
| Targeting pathways for genetic manipulations in Saccharomyces cerevisiae for improving artemisinin acid production via 13C metabolic flux analysis Y Tang, E Paradise, S Rodriguez, M Ouellet, J Chu, D Chen, R Chan, ... The Annual Meeting and Exhibition 2007, 2007 | | 2007 |
| Engineering Saccharomyces Cerevisiae for High-level Terpenoid Production EM Paradise University of California, Berkeley, 2006 | | 2006 |
| Metabolic engineering of Saccharomyces cerevisiae for the production of isoprenoids. EM Paradise ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 225, U222-U222, 2003 | | 2003 |
